Announcements Trials
Browse Landscape

Phase

Phase 2 59Phase 1 22Phase NA 10Phase 3 8Phase 1/2 8Phase 4 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia 3Myelodysplastic Syndromes 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Anemia, Refractory, with Excess of Blasts 2Warts 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Seminoma 1Recurrence 1Neutropenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1Infections 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Febrile Neutropenia 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1Breast Neoplasms 1Anemia, Refractory 1Agammaglobulinemia 1

Interventions

Rituximab 4Etoposide 4Whole-Body Irradiation 2Gemcitabine 2Cyclophosphamide 2umbralisib 1ublituximab 1rasburicase 1pegfilgrastim 1fludarabine phosphate 1fludarabine 1epratuzumab 1aldesleukin 1Trimethoprim, Sulfamethoxazole Drug Combination 1Thiotepa 1Radioimmunodetection 1Prednisone 1Oxaliplatin 1Nivolumab 1Melphalan 1Leucovorin 1Lenalidomide 1Immunoglobulins, Intravenous 1Hizentra 1Filgrastim 1Doxorubicin 1Cytarabine 1Ciprofloxacin 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Lymphoma, Non-Hodgkin × Filgrastim × Clear all
NCT01046825 2026-06-02

Mature B-Cell Lymphoma And Leukemia Study III

St. Jude Children's Research Hospital

Phase 2/3 Active not recruiting
128 enrolled 12 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡